Clare Rollie

Clare Rollie

Auto-generated profile, based on publicly available information

Clare Rollie

ESI, Biosciences, University of Exeter, Penryn, UK.

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2018 in Cell
Verified
Journal Article
Open access
MLMariann Landsberger
Mariann Landsberger
SGSylvain Gandon
Sylvain Gandon
SMSean Meaden
Sean Meaden
CRClare Rollie
Clare Rollie
ACAnne Chevallereau
Anne Chevallereau
SHStineke Van Houte
Stineke Van Houte
Some phages encode anti-CRISPR (acr) genes, which antagonize bacterial CRISPR-Cas immune systems by binding components of its machinery, but it is less clear how deployment of these acr genes impacts phage replication and epidemiology. Here, we demonstrate that bacteria with CRISPR-Cas resistance are still partially immune to Acr-encoding phage. As a consequence, Acr-phages often need to cooperate in order to overcome CRISPR resistance, with a first phage blocking the host CRISPR-Cas immune system to allow a second Acr-phage to successfully replicate. This cooperation leads to epidemiological tipping points in which the initial density of Acr-phage tips the balance from phage extinction to a phage epidemic. Furthermore, both higher levels of CRISPR-Cas immunity and weaker Acr activities shift the tipping points toward higher initial phage densities. Collectively, these data help elucidate how interactions between phage-encoded immune suppressors and the CRISPR systems they target shape bacteria-phage population dynamics.

23 October 2019 in Nature
Verified
Journal Article
Closed access
PDF file
EAEllinor O. Alseth
Ellinor O. Alseth
EPElizabeth Pursey
Elizabeth Pursey
ALAdela M. Luján
Adela M. Luján
IMIsobel McLeod
Isobel McLeod
CRClare Rollie
Clare Rollie
EWEdze R. Westra
Edze R. Westra

18 August 2015 in eLife
Verified
Journal Article
Open access
CRClare Rollie
Clare Rollie
SSStefanie Schneider
Stefanie Schneider
ABAnna Sophie Brinkmann
Anna Sophie Brinkmann
Ed BoltEd Bolt
Ed Bolt
MWMalcolm F White
Malcolm F White
The adaptive prokaryotic immune system CRISPR-Cas provides RNA-mediated protection from invading genetic elements. The fundamental basis of the system is the ability to capture small pieces of foreign DNA for incorporation into the genome at the CRISPR locus, a process known as Adaptation, which is dependent on the Cas1 and Cas2 proteins. We demonstrate that Cas1 catalyses an efficient trans-esterification reaction on branched DNA substrates, which represents the reverse- or disintegration reaction. Cas1 from both Escherichia coli and Sulfolobus solfataricus display sequence specific activity, with a clear preference for the nucleotides flanking the integration site at the leader-repeat 1 boundary of the CRISPR locus. Cas2 is not required for this activity and does not influence the specificity. This suggests that the inherent sequence specificity of Cas1 is a major determinant of the adaptation process.

22 January 2020 in Nature
Verified
Journal Article
Closed access
PDF file
CRClare Rollie
Clare Rollie
ACAnne Chevallereau
Anne Chevallereau
BWBridget N. J. Watson
Bridget N. J. Watson
TCTe-Yuan Chyou
Te-Yuan Chyou
OFOlivier Fradet
Olivier Fradet
EWEdze R. Westra
Edze R. Westra

8 December 2017 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
CRClare Rollie
Clare Rollie
SGShirley Graham
Shirley Graham
CRChristophe Rouillon
Christophe Rouillon
MWMalcolm F White
Malcolm F White
The CRISPR–Cas system for prokaryotic adaptive immunity provides RNA-mediated protection from viruses and mobile genetic elements. Adaptation is dependent on the Cas1 and Cas2 proteins along with varying accessory proteins. Here we analyse the process in Sulfolobus solfataricus, showing that while Cas1 and Cas2 catalyze spacer integration in vitro, host factors are required for specificity. Specific integration also requires at least 400 bp of the leader sequence, and is dependent on the presence of hydrolysable ATP, suggestive of an active process that may involve DNA remodelling. Specific spacer integration is associated with processing of prespacer 3′ ends in a PAM-dependent manner. This is reflected in PAM-dependent processing of prespacer 3′ ends in vitro in the presence of cell lysate or the Cas4 nuclease, in a reaction consistent with PAM-directed binding and protection of prespacer DNA. These results highlight the diverse interplay between CRISPR–Cas elements and host proteins across CRISPR types.

25 March 2019 in Philosophical Transactions of the Royal Society B: Biological Sciences
Verified
Journal Article
Open access
ACAnne Chevallereau
Anne Chevallereau
SMSean Meaden
Sean Meaden
SHStineke van Houte
Stineke van Houte
EWEdze R. Westra
Edze R. Westra
CRClare Rollie
Clare Rollie
CRISPR-Cas immune systems are present in around half of bacterial genomes. Given the specificity and adaptability of this immune mechanism, it is perhaps surprising that they are not more widespread. Recent insights into the requirement for specific host factors for the function of some CRISPR-Cas subtypes, as well as the negative epistasis between CRISPR-Cas and other host genes, have shed light on potential reasons for the partial distribution of this immune strategy in bacteria. In this study, we examined how mutations in the bacterial mismatch repair system, which are frequently observed in natural and clinical isolates and cause elevated host mutation rates, influence the evolution of CRISPR-Cas–mediated immunity. We found that hosts with a high mutation rate very rarely evolved CRISPR-based immunity to phage compared to wild-type hosts. We explored the reason for this effect and found that the higher frequency at which surface mutants pre-exist in the mutator host background causes them to rapidly become the dominant phenotype under phage infection. These findings suggest that natural variation in bacterial mutation rates may, therefore, influence the distribution of CRISPR-Cas adaptive immune systems. This article is part of a discussion meeting issue ‘The ecology and evolution of prokaryotic CRISPR-Cas adaptive immune systems’.